ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 194 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,611,000 | -77.2% | 30,550 | -69.0% | 0.19% | -77.2% |
| Q2 2018 | $11,431,000 | +128.3% | 98,631 | +59.3% | 0.83% | +119.1% |
| Q1 2018 | $5,008,000 | +182.0% | 61,901 | +63.0% | 0.38% | +211.6% |
| Q3 2017 | $1,776,000 | +361.3% | 37,967 | +203.5% | 0.12% | +348.1% |
| Q1 2017 | $385,000 | +4.6% | 12,510 | -9.6% | 0.03% | 0.0% |
| Q3 2016 | $368,000 | -70.2% | 13,832 | -74.3% | 0.03% | -78.4% |
| Q3 2013 | $1,234,000 | – | 53,863 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |